Table 7.

Clinical characteristics and survival in anaplastic thyroid carcinoma

	Years	Patient (M/F)	Age (yrs) (range)	Survival (mos)	Survival 1 year (%)
McIver et al. (2001)	1949–1999	54/80	67 (mean)	3	9.7%
Junor et al. (1992)	1961–1986	27/64	70 (median) (38–92)	5	∼20%
Levendag et al. (1993)	1970–1986	17/34	67 (mean) (31–89)	2.7–3.4	6%
Voutilainen et al. (1999)	1967–1994	7/26	66 (mean) (36–89)	2.5	9.7%
Tan et al. (1995)	1968–1992	10/11	65 (mean) (38–83)	4.5	∼23%
Pierie et al. (2002)	1969–1999	22/45	73 (median) (40–92)	∼6	35%
Kim & Leeper (1983)	1979–1983	3/6	69 (mean) (54–79)	10	22%
Kobayashi et al. (1996)	1971–1993	9/28	68 (median) (34–82)	3	0–20%
Schlumberger et al. (1991)	1981–1991	9/11	61 (median) (27–82)	–	15%
Chemotherapy Committee. The Japanese Society of Thyroid Surgery (1995)	1992–1994	6/11	67 (median) (50–74)	–	–
Mitchell et al. (1999)	1991–1995	9/8	71 (median) (51–85)	2.5	0%
Tennvall et al. (2002)	1984–1999	17/38	76 (median) (46–94)	3.5	16%
Haigh et al. (2001)	1973–1998	13/20	69 (median) (47–80)	3–43	0–75%
Besic et al. (2005)	1972–2003	58/130	68 (median)	3	13%
De Crevoisier et al. (2004)	1990–2000	12/18	59 (mean) (40–79)	10	46%
Wang et al. (2006)	1983–2004	25/22	69 (median) (39–90)	5.6	–
Brignardello et al. (2007)	2000–2005	9/18	70 (mean) (46–89)	3.9	∼25%
Ain et al. (2000)	1996–1999	13/6	58 (median) (47–86)	6	∼30%